Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7) - Université de Rennes Access content directly
Journal Articles Blood Year : 2015

Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7)

Yves Bertrand
  • Function : Author
  • PersonId : 899520
Nicolas Blin
Emmanuelle Tavernier
  • Function : Author
Francoise Mazingue
  • Function : Author
Genevieve Plat
  • Function : Author
José Fernandes
  • Function : Author
Luc Fornecker
  • Function : Author
Thibault Leguay
  • Function : Author
Alina Ferster
Cecile Bonin
  • Function : Author
Yann Godfrin
  • Function : Author
Iman El Hariry
  • Function : Author

Abstract

Conference: 57th Annual Meeting of the American-Society-of-Hematology - Orlando, FL - DEC 05-08, 2015
No file

Dates and versions

hal-01290427 , version 1 (18-03-2016)

Identifiers

  • HAL Id : hal-01290427 , version 1

Cite

Xavier Thomas, Yves Bertrand, André Baruchel, Nicolas Blin, Emmanuelle Tavernier, et al.. Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7). Blood, 2015, 126 (23), pp.2492. ⟨hal-01290427⟩
212 View
0 Download

Share

Gmail Facebook X LinkedIn More